title,time_published,url,ticker,relevance_score,ticker_sentiment_label,ticker_sentiment_score
Why JanOne Shares Are Trading Higher By 19%; Here Are 20 Stocks Moving Premarket - JanOne  ( NASDAQ:JAN ) ,20240513T094610,https://www.benzinga.com/news/24/05/38783309/why-janone-shares-are-trading-higher-by-19-here-are-20-stocks-moving-premarket,SNY,0.067536,Somewhat-Bullish,0.200818
"Earnings Scheduled For April 28, 2022",20220428T085040,https://www.benzinga.com/news/earnings/22/04/26860440/earnings-scheduled-for-april-28-2022,SNY,0.014477,Neutral,-0.001809
"Global Tissue Banking Market to Exhibit Growth at a Considerable CAGR of ~6% by 2030, Assesses DelveInsight",20240409T214100,https://www.prnewswire.com/news-releases/global-tissue-banking-market-to-exhibit-growth-at-a-considerable-cagr-of-6-by-2030-assesses-delveinsight-302110459.html,SNY,0.022991,Neutral,0.037011
"Biotech Stock Roundup: KYMR, IDYA, QURE Soar on Study Data, HLVX Tanks on Study Failure",20240711T131200,https://www.zacks.com/stock/news/2300042/biotech-stock-roundup-kymr-idya-qure-soar-on-study-data-hlvx-tanks-on-study-failure,SNY,0.156207,Somewhat-Bullish,0.15601
"Biotech Stock Roundup: BMY Grabs MRTX, AKRO Down on Study Data, ALNY Faces Setback",20231012T122400,https://www.zacks.com/stock/news/2164807/biotech-stock-roundup-bmy-grabs-mrtx-akro-down-on-study-data-alny-faces-setback,SNY,0.033751,Neutral,0.032519
"Dow Tumbles 200 Points; Darden Restaurants Posts Upbeat Profit - Cisco Systems  ( NASDAQ:CSCO ) , Darden Restaurants  ( NYSE:DRI ) ",20230921T183004,https://www.benzinga.com/news/earnings/23/09/34803375/dow-tumbles-200-points-darden-restaurants-posts-upbeat-profit,SNY,0.107255,Neutral,0.129334
"Nasdaq Down Over 1%; US Initial Jobless Claims Fall More Than Expected - MSP Recovery  ( NASDAQ:LIFW ) , Neptune Wellness Solns  ( NASDAQ:NEPT ) ",20230921T135921,https://www.benzinga.com/news/earnings/23/09/34793343/nasdaq-down-over-1-us-initial-jobless-claims-fall-more-than-expected,SNY,0.124809,Neutral,0.137247
Neuromuscular Disease Therapeutics Market size to grow by USD 65.13 billion from 2022-2027| Aquestive ... - PR Newswire,20231201T183000,https://www.prnewswire.com/news-releases/neuromuscular-disease-therapeutics-market-size-to-grow-by-usd-65-13-billion-from-2022-2027-aquestive-therapeutics-inc-bausch-health-companies-inc-biogen-inc-and-more-among-the-major-companies-in-the-market--technavio-302002042.html,SNY,0.059636,Neutral,0.014995
"DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors - DBV Technologies  ( NASDAQ:DBVT ) , Aquestive Therapeutics  ( NASDAQ:AQST ) ",20221003T203000,https://www.benzinga.com/pressreleases/22/10/g29126135/dbv-technologies-announces-appointment-of-new-chair-of-its-audit-committee-and-appointment-of-dani,SNY,0.038284,Neutral,0.047891
DBV Technologies Announces Appointment of New Chair of its Audit Committee and Appointment of Daniele Guyot-Caparros to Board of Directors,20221003T203000,https://www.globenewswire.com/news-release/2022/10/03/2527329/0/en/DBV-Technologies-Announces-Appointment-of-New-Chair-of-its-Audit-Committee-and-Appointment-of-Daniele-Guyot-Caparros-to-Board-of-Directors.html,SNY,0.033656,Neutral,0.047894
Colorectal Cancer Treatment Drug Market to Show Immense Growth During the Study Period  ( 2019-2032 )  | DelveInsight,20231121T220100,https://www.prnewswire.com/news-releases/colorectal-cancer-treatment-drug-market-to-show-immense-growth-during-the-study-period-20192032--delveinsight-301994315.html,SNY,0.046184,Neutral,-0.032778
"Pancreatic Endocrine Tumor Market is Expected to Expand at a Healthy Growth Rate by 2032, Assesses DelveInsight | Key Companies - Merck, Theradex, SynerGene, Mirati, Novartis, Syntrix Biosystems, Eli Lilly, Boehringer Ingelheim",20230803T210100,https://www.prnewswire.com/news-releases/pancreatic-endocrine-tumor-market-is-expected-to-expand-at-a-healthy-growth-rate-by-2032-assesses-delveinsight--key-companies---merck-theradex-synergene-mirati-novartis-syntrix-biosystems-eli-lilly-boehringer-ingelheim-301892397.html,SNY,0.02074,Neutral,-0.020974
Why Hill International Shares Are Trading Higher By 58%: Here Are 25 Stocks Moving Premarket,20220817T100654,https://www.benzinga.com/news/22/08/28530257/why-hill-international-shares-are-trading-higher-by-58-here-are-25-stocks-moving-premarket,SNY,0.091509,Neutral,-0.141686
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",20231214T221500,https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,SNY,0.078099,Neutral,0.0
MacroGenics  ( MGNX )  Q3 2024 Earnings Call Transcript,20241106T031514,https://www.fool.com/earnings/call-transcripts/2024/11/05/macrogenics-mgnx-q3-2024-earnings-call-transcript/,SNY,0.008183,Neutral,0.100133
Crude Oil Down 1%; Sweetgreen Shares Spike Higher - Macrogenics  ( NASDAQ:MGNX ) ,20240510T183023,https://www.benzinga.com/news/24/05/38768201/crude-oil-down-1-sweetgreen-shares-spike-higher,SNY,0.077094,Somewhat-Bullish,0.174502
Nasdaq Moves Lower; US Consumer Sentiment Falls In May - Novavax  ( NASDAQ:NVAX ) ,20240510T162224,https://www.benzinga.com/news/earnings/24/05/38765474/nasdaq-moves-lower-us-consumer-sentiment-falls-in-may,SNY,0.081276,Somewhat-Bullish,0.175689
"Dow Jumps Over 100 Points; DNOW Posts Downbeat Earnings - Dnow  ( NYSE:DNOW ) , Evolv Technologies  ( NASDAQ:EVLV ) ",20240510T140059,https://www.benzinga.com/news/24/05/38761518/dow-jumps-over-100-points-dnow-posts-downbeat-earnings,SNY,0.075874,Somewhat-Bullish,0.174196
MacroGenics  ( MGNX )  Q4 2023 Earnings Call Transcript,20240308T053017,https://www.fool.com/earnings/call-transcripts/2024/03/08/macrogenics-mgnx-q4-2023-earnings-call-transcript/,SNY,0.012228,Neutral,0.081069
DRI Healthcare Trust Reports Fourth Quarter and Fiscal 2023 Results,20240228T220000,https://www.newswire.ca/news-releases/dri-healthcare-trust-reports-fourth-quarter-and-fiscal-2023-results-808176485.html,SNY,0.008908,Somewhat-Bullish,0.164782
MacroGenics  ( MGNX )  Q3 2023 Earnings Call Transcript,20231107T061542,https://www.fool.com/earnings/call-transcripts/2023/11/07/macrogenics-mgnx-q3-2023-earnings-call-transcript/,SNY,0.014595,Neutral,0.094169
"Breast Cancer Monoclonal Antibodies Market to grow by USD 15 billion from 2022 to 2027, North America to account ... - PR Newswire",20230918T091500,https://www.prnewswire.com/news-releases/breast-cancer-monoclonal-antibodies-market-to-grow-by-usd-15-billion-from-2022-to-2027-north-america-to-account-for-42-of-market-growth---technavio-301929309.html,SNY,0.043108,Neutral,0.0
3 Under-the-Radar Biotech Stocks to Buy in 2023,20230819T114000,https://www.fool.com/investing/2023/08/19/3-under-the-radar-biotech-stocks-to-buy-in-2023/,SNY,0.097259,Neutral,0.013139
MacroGenics'  ( MGNX )  Shares Jump 19% in One Week: Here's Why,20230814T151900,https://www.zacks.com/stock/news/2136295/macrogenics-mgnx-shares-jump-19-in-one-week-heres-why,SNY,0.374714,Somewhat-Bullish,0.184453
Why Shares of MacroGenics Are Jumping Thursday,20230810T163341,https://www.fool.com/investing/2023/08/10/why-shares-of-macrogenics-are-jumping-thursday/,SNY,0.459624,Neutral,0.10264
MacroGenics  ( MGNX )  Q2 2023 Earnings Call Transcript,20230810T033023,https://www.fool.com/earnings/call-transcripts/2023/08/09/macrogenics-mgnx-q2-2023-earnings-call-transcript/,SNY,0.036277,Neutral,0.10025
MacroGenics Provides Update on Corporate Progress and Second Quarter 2023 Financial Results - Macrogenics  ( NASDAQ:MGNX ) ,20230809T200100,https://www.benzinga.com/pressreleases/23/08/g33677875/macrogenics-provides-update-on-corporate-progress-and-second-quarter-2023-financial-results,SNY,0.183372,Somewhat-Bullish,0.176532
Antibody-drug Conjugates Clinical Trial Pipeline Experiences Momentum: DelveInsight Estimates a Diverse Pipeline Comprising 180+ Companies Working in the Domain,20230626T210100,https://www.prnewswire.com/news-releases/antibody-drug-conjugates-clinical-trial-pipeline-experiences-momentum-delveinsight-estimates-a-diverse-pipeline-comprising-180-companies-working-in-the-domain-301862784.html,SNY,0.083468,Neutral,-0.023781
Here's Why You Should Add ImmunoGen  ( IMGN )  to Your Portfolio Now,20230519T150900,https://www.zacks.com/stock/news/2097447/heres-why-you-should-add-immunogen-imgn-to-your-portfolio-now,SNY,0.073098,Neutral,0.138138
MacroGenics  ( MGNX )  Q1 2023 Earnings Call Transcript,20230510T043040,https://www.fool.com/earnings/call-transcripts/2023/05/10/macrogenics-mgnx-q1-2023-earnings-call-transcript/,SNY,0.028277,Neutral,0.099957
MacroGenics  ( MGNX )  Q4 2022 Earnings Call Transcript,20230316T030035,https://www.fool.com/earnings/call-transcripts/2023/03/15/macrogenics-mgnx-q4-2022-earnings-call-transcript/,SNY,0.0379,Somewhat-Bullish,0.159208
Provention  ( PRVB )  Skyrockets 260% on Buyout Offer From Sanofi,20230314T163200,https://www.zacks.com/stock/news/2065615/provention-prvb-skyrockets-260-on-buyout-offer-from-sanofi,SNY,0.724016,Somewhat-Bullish,0.220782
"Illumina, Seagen And Other Big Stocks Moving Higher On Monday - Agenus  ( NASDAQ:AGEN ) , First Majestic Silver  ( NYSE:AG ) ",20230313T145550,https://www.benzinga.com/news/23/03/31322709/illumina-seagen-and-other-big-stocks-moving-higher-on-monday,SNY,0.08183,Somewhat-Bullish,0.287233
DRI Healthcare Trust Announces Acquisition of a Royalty Interest in the Worldwide Sales of TZIELDâ„¢  ( teplizumab-mzwv )  and Updates Long-Term Cash Receipts Outlook,20230308T223000,https://www.newswire.ca/news-releases/dri-healthcare-trust-announces-acquisition-of-a-royalty-interest-in-the-worldwide-sales-of-tzield-tm-teplizumab-mzwv-and-updates-long-term-cash-receipts-outlook-870382808.html,SNY,0.030408,Neutral,0.060126
Provention  ( PRVB )  Gets FDA Nod for Drug That Delays T1D Onset,20221118T151500,https://www.zacks.com/stock/news/2019947/provention-prvb-gets-fda-nod-for-drug-that-delays-t1d-onset,SNY,0.444919,Bullish,0.543637
Why Provention Bio  ( PRVB )  Shares Are Trading Higher Premarket Today? - Provention Bio  ( NASDAQ:PRVB ) ,20221118T113942,https://www.benzinga.com/general/biotech/22/11/29780945/first-drug-that-can-delay-onset-of-type-1-diabetes-gets-fda-approval-after-multiple-regulatory-hu,SNY,0.268294,Neutral,0.055124
U.S. FDA greenlights Provention Bio's diabetes drug,20221117T233200,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-greenlights-provention-bios-diabetes-drug-2022-11-17/,SNY,0.34729,Somewhat-Bullish,0.162723
Provention Bio Reports Third Quarter 2022 Financial Results and Provides Business Update,20221103T110000,https://www.prnewswire.com/news-releases/provention-bio-reports-third-quarter-2022-financial-results-and-provides-business-update-301667012.html,SNY,0.156461,Somewhat-Bullish,0.164696
"The Daily Biotech Pulse: Europe Approves Second Round Of Booster Doses of mRNA COVID-19 Vaccines, Perrigo Seeks Approval For First OTC Birth Control Pill, MacroGenics Closes Head & Cancer Study After Patient Death",20220711T125503,https://www.benzinga.com/general/biotech/22/07/28015717/the-daily-biotech-pulse-europe-approves-second-round-of-booster-doses-of-mrna-covid-19-vaccines-p,SNY,0.236396,Somewhat-Bearish,-0.172528
"Regional banks pace decliners, as biotech deals lift Seagen and Provention Bio",20230313T143200,https://www.marketwatch.com/story/regional-banks-pace-decliners-as-biotech-deals-lift-seagen-and-provention-bio-78a5d161,SNY,0.255641,Bullish,0.414305
"Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial",20220803T141314,https://www.benzinga.com/general/biotech/22/08/28331170/biotech-daily-mercks-two-combo-cancer-trials-miss-main-goal-approval-for-sinovacs-covid-19-shot-f,SNY,0.098659,Neutral,0.0
Why Is Disney Higher By More Than 7%: Here Are 40 Stocks Moving Premarket,20220811T111757,https://www.benzinga.com/news/22/08/28450774/why-is-disney-higher-by-more-than-7-here-are-40-stocks-moving-premarket,SNY,0.079788,Neutral,-0.104709
"Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday - Apple  ( NASDAQ:AAPL ) , Abeona Therapeutics  ( NASDAQ:ABEO ) ",20221010T092851,https://www.benzinga.com/news/22/10/29198222/why-nvidia-microsoft-and-amazon-shares-traded-lower-here-are-73-biggest-movers-from-friday,SNY,0.023556,Neutral,0.134046
Practice of law: best examples in legal work,20230922T040009,https://www.ft.com/content/e3806267-281d-47b0-9b6f-dbd20a1437c1,SNY,0.008206,Neutral,0.129139
"Nasdaq Surges 100 Points; First Wave BioPharma Shares Spike Higher - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T183007,https://www.benzinga.com/news/earnings/23/09/34591297/nasdaq-surges-100-points-first-wave-biopharma-shares-spike-higher,SNY,0.068896,Somewhat-Bullish,0.25357
"Crude Oil Rises Sharply; BIOLASE Shares Plunge - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T161953,https://www.benzinga.com/news/earnings/23/09/34587190/crude-oil-rises-sharply-biolase-shares-plunge,SNY,0.069495,Somewhat-Bullish,0.253722
"Dow Jumps Over 200 Points; US Producer Prices Rise In August - Biolase  ( NASDAQ:BIOL ) , Clearmind Medicine  ( NASDAQ:CMND ) ",20230914T140356,https://www.benzinga.com/news/earnings/23/09/34582871/dow-jumps-over-200-points-us-producer-prices-rise-in-august,SNY,0.079392,Somewhat-Bullish,0.257189
"US Stocks Mostly Higher; Dow Rises 75 Points - Bluegreen Vacations  ( NYSE:BVH ) , Calliditas Therapeutics  ( NASDAQ:CALT ) ",20230313T141541,https://www.benzinga.com/news/earnings/23/03/31321718/us-stocks-mostly-higher-dow-rises-75-points,SNY,0.073321,Somewhat-Bullish,0.181728
"The Week Ahead In Biotech  ( June 5-11 ) : Adcom Test For Novavax, ASCO Presentations, Enzo Biochem Earnings And More",20220605T200922,https://www.benzinga.com/general/biotech/22/06/27558552/the-week-ahead-in-biotech-june-5-11-adcom-test-for-novavax-asco-presentations-enzo-biochem-earnin,SNY,0.121866,Neutral,0.042455
"Genpact Posts Upbeat Earnings, Joins Groupon, Natera, Funko, CarGurus And Other Big Stocks Moving Higher On Friday - Groupon  ( NASDAQ:GRPN ) ",20240510T144827,https://www.benzinga.com/news/24/05/38762708/genpact-posts-upbeat-earnings-joins-groupon-natera-funko-cargurus-and-other-big-stocks-moving-higher,SNY,0.057079,Somewhat-Bullish,0.250003
RNAi Therapeutics Global Market to 2027: Rising Utilization in Oncology Pharmaceuticals and Accelerating Growth Rates of Infectious Diseases Drives Growth,20230316T184500,https://www.prnewswire.com/news-releases/rnai-therapeutics-global-market-to-2027-rising-utilization-in-oncology-pharmaceuticals-and-accelerating-growth-rates-of-infectious-diseases-drives-growth-301774181.html,SNY,0.044801,Neutral,0.145391
Anaveon appoints Dieter Weinand as Chair of its Board of Directors,20240730T060000,https://www.benzinga.com/pressreleases/24/07/g40028529/anaveon-appoints-dieter-weinand-as-chair-of-its-board-of-directors,SNY,0.090134,Neutral,0.038482
Umoja Biopharma Appoints Dieter Weinand as the Chair of its Board of Directors,20221214T123000,https://www.benzinga.com/pressreleases/22/12/g30073538/umoja-biopharma-appoints-dieter-weinand-as-the-chair-of-its-board-of-directors,SNY,0.055751,Neutral,0.047895
Immuno-oncology Consolidating its Presence in Most Major Types of Cancer | Globaldata Plc,20220705T140000,https://www.globenewswire.com/news-release/2022/07/05/2474145/0/en/Immuno-oncology-Consolidating-its-Presence-in-Most-Major-Types-of-Cancer-Globaldata-Plc.html,SNY,0.030755,Neutral,0.003514
Replimune To Present at the 2022 American Society of Clinical Oncology  ( ASCO )  Annual Meeting,20220526T211500,https://www.benzinga.com/pressreleases/22/05/g27432191/replimune-to-present-at-the-2022-american-society-of-clinical-oncology-asco-annual-meeting,SNY,0.030712,Neutral,0.002078
Replimune To Present at the 2022 American Society of Clinical Oncology  ( ASCO )  Annual Meeting,20220526T211500,https://www.globenewswire.com/news-release/2022/05/26/2451683/0/en/Replimune-To-Present-at-the-2022-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html,SNY,0.034615,Neutral,0.003278
"The Daily Biotech Pulse: Roche's Lung Cancer Combo Therapy Flunks Late-Stage Study, Adagio Spikes On Positive COVID Antibody Data, Amylyx Awaits Adcom Verdict",20220330T114641,https://www.benzinga.com/general/biotech/22/03/26367702/the-daily-biotech-pulse-roches-lung-cancer-combo-therapy-flunks-late-stage-study-adagio-spikes-on,SNY,0.087744,Neutral,0.060911
"Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies",20220330T110000,https://www.benzinga.com/pressreleases/22/03/g26367562/replimune-provides-new-clinical-data-broad-program-update-and-future-development-strategy-for-its-,SNY,0.014334,Neutral,0.002118
"Replimune Provides New Clinical Data, Broad Program Update and Future Development Strategy for its Tumor-Directed Oncolytic Immunotherapies",20220330T110000,https://www.globenewswire.com/news-release/2022/03/30/2412692/0/en/Replimune-Provides-New-Clinical-Data-Broad-Program-Update-and-Future-Development-Strategy-for-its-Tumor-Directed-Oncolytic-Immunotherapies.html,SNY,0.014526,Neutral,0.00335
"Sonos, Bumble And Some Other Big Stocks Moving Lower In Today's Pre-Market Session",20220811T100303,https://www.benzinga.com/news/22/08/28449050/sonos-bumble-and-some-other-big-stocks-moving-lower-in-todays-pre-market-session,SNY,0.122581,Neutral,-0.117735
"Chefs' Warehouse, Chart Industries And Some Other Big Stocks Moving Lower On Thursday - Cano Health  ( NYSE:CANO ) , The Chefs' Warehouse  ( NASDAQ:CHEF ) ",20221208T160409,https://www.benzinga.com/news/22/12/30009897/chefs-warehouse-chart-industries-and-some-other-big-stocks-moving-lower-on-thursday,SNY,0.147818,Somewhat-Bearish,-0.189072
Medical Second Opinion Global Market to Register Stunning Growth at a CAGR of ~17% by 2028 | DelveInsight,20230821T210100,https://www.prnewswire.com/news-releases/medical-second-opinion-global-market-to-register-stunning-growth-at-a-cagr-of-17-by-2028--delveinsight-301905294.html,SNY,0.024347,Neutral,0.052734
U.S. Stocks May Regain Ground Following Recent Weakness,20231030T131506,https://markets.businessinsider.com/news/stocks/u-s-stocks-may-regain-ground-following-recent-weakness-1032753981,SNY,0.045786,Neutral,-0.069083
"Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday - Agenus  ( NASDAQ:AGEN ) , Atlis Motor Vehicles  ( NASDAQ:AMV ) ",20221007T102920,https://www.benzinga.com/news/22/10/29181534/why-cyclerion-therapeutics-shares-traded-lower-by-around-38-here-are-70-biggest-movers-from-yesterda,SNY,0.029618,Neutral,0.139044
53 Biggest Movers From Yesterday,20220330T073305,https://www.benzinga.com/news/22/03/26365918/53-biggest-movers-from-yesterday,SNY,0.068404,Neutral,0.005661
36 Stocks Moving In Tuesday's Mid-Day Session,20220329T160304,https://www.benzinga.com/news/22/03/26353865/36-stocks-moving-in-tuesdays-mid-day-session,SNY,0.092408,Neutral,0.001932
SNY's Tolebrutinib Gets FDA Breakthrough Therapy Tag for nrSPMS,20241213T155800,https://www.zacks.com/stock/news/2383449/snys-tolebrutinib-gets-fda-breakthrough-therapy-tag-for-nrspms,SNY,0.253646,Somewhat-Bullish,0.226168
Inhibrx  ( INBX )  Up 6% on Sale of Rare Disease Drug to Sanofi,20240123T193000,https://www.zacks.com/stock/news/2214518/inhibrx-inbx-up-6-on-sale-of-rare-disease-drug-to-sanofi,SNY,0.567965,Somewhat-Bullish,0.248232
Why Moderna  ( MRNA )  Stock Price Was Up 13% on Tuesday,20240103T185600,https://www.zacks.com/stock/news/2205244/why-moderna-mrna-stock-price-was-up-13-on-tuesday,SNY,0.04497,Neutral,0.045947
MeiraGTx  ( MGTX )  Stock Surges 35% in a Month: Here's Why,20240102T171700,https://www.zacks.com/stock/news/2204585/meiragtx-mgtx-stock-surges-35-in-a-month-heres-why,SNY,0.344074,Neutral,0.127683
Sanofi  ( SNY )  Terminates Pompe Disease Deal as FTC Objects,20231212T142000,https://www.zacks.com/stock/news/2196713/sanofi-sny-terminates-pompe-disease-deal-as-ftc-objects,SNY,0.459624,Neutral,-0.021088
"Triple-Negative Breast Cancer Market to Accelerate Substantially During the Forecast Period  ( 2023-2032 ) , Examines DelveInsight | Key Companies to Watch - Roche, AbbVie, AstraZeneca, BeiGene, GlaxoSmithKline, Genentech, Eli Lilly, Novartis",20230906T210100,https://www.prnewswire.com/news-releases/triple-negative-breast-cancer-market-to-accelerate-substantially-during-the-forecast-period-20232032-examines-delveinsight--key-companies-to-watch---roche-abbvie-astrazeneca-beigene-glaxosmithkline-genentech-eli-lilly--301918858.html,SNY,0.022494,Neutral,0.023078
Regeneron Reports Fourth Quarter and Full Year 2022 Financial and Operating Results,20230203T113000,https://www.globenewswire.com/news-release/2023/02/03/2601193/0/en/Regeneron-Reports-Fourth-Quarter-and-Full-Year-2022-Financial-and-Operating-Results.html,SNY,0.076777,Neutral,0.071363
"The Daily Biotech Pulse: Much Awaited FDA Nod For Novavax's COVID-19 Shot, DSMB Suggests ContraFect To Stop Antimicrobial-Resistant Infection Study, CytomX Restructures",20220714T130111,https://www.benzinga.com/general/biotech/22/07/28062629/the-daily-biotech-pulse-much-awaited-fda-nod-for-novavaxs-covid-19-shot-dsmb-suggests-contrafect-,SNY,0.114137,Neutral,0.056425
"The Evolving Market Dynamics of Factor-based Bleeding Disorders: Hemophilia A, Hemophilia B, and Von Willebrand Disease | Key Analysis by DelveInsight",20231009T210100,https://www.prnewswire.com/news-releases/the-evolving-market-dynamics-of-factor-based-bleeding-disorders-hemophilia-a-hemophilia-b-and-von-willebrand-disease--key-analysis-by-delveinsight-301950491.html,SNY,0.036338,Neutral,0.047119
"Large Granular Lymphocyte Leukemia Market is Projected to Grow During the Study Period  ( 2019-2032 ) , Assesses DelveInsight | Key Companies - Bristol Myers Squibb, Innate Pharma, Kymera Therapeutics, EUSA Pharma, Abcuro, Dren Bio, Novotech",20231016T210100,https://www.prnewswire.com/news-releases/large-granular-lymphocyte-leukemia-market-is-projected-to-grow-during-the-study-period-20192032-assesses-delveinsight--key-companies---bristol-myers-squibb-innate-pharma-kymera-therapeutics-eusa-pharma-abcuro-dren-bio-n-301957023.html,SNY,0.025845,Neutral,-0.023726
"Acute Lymphocytic Leukemia Market to Accelerate Substantially by 2032, Assesses DelveInsight | Key Companies in the Market - Beam, Pfizer, Genentech, AbbVie, Fate, Roche, Ascentage, Janssen, Jazz, ADC, Kymera, Syndax, ImmunoGen",20230913T210100,https://www.prnewswire.com/news-releases/acute-lymphocytic-leukemia-market-to-accelerate-substantially-by-2032-assesses-delveinsight--key-companies-in-the-market---beam-pfizer-genentech-abbvie-fate-roche-ascentage-janssen-jazz-adc-kymera-syndax-immunogen-301925772.html,SNY,0.043778,Neutral,0.034443
LAVA Therapeutics Announces Appointment of Fred M. Powell as Chief Financial Officer,20221101T110000,https://www.globenewswire.com/news-release/2022/11/01/2545292/0/en/LAVA-Therapeutics-Announces-Appointment-of-Fred-M-Powell-as-Chief-Financial-Officer.html,SNY,0.073546,Neutral,0.016266
Will Seagen's  ( SGEN )  Portfolio of Drugs Help Combat Rivalry?,20221004T140500,https://www.zacks.com/stock/news/1987853/will-seagens-sgen-portfolio-of-drugs-help-combat-rivalry,SNY,0.256538,Somewhat-Bullish,0.164547
Molecular Glues Clinical Trial Pipeline Appears Robust With 10+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight,20240711T213100,https://www.prnewswire.com/news-releases/molecular-glues-clinical-trial-pipeline-appears-robust-with-10-key-pharma-companies-actively-working-in-the-therapeutics-segment--delveinsight-302194515.html,SNY,0.024904,Neutral,0.02309
